Viva Cyte Pjattaforma Software Suite minn Livia Stevenin

Id-disinn Viva Cyte Pjattaforma Software Suite minn Livia Stevenin huwa rebbieħ stmat ħafna tal-prestiġjuż 2025 Premju A' Design Award tal-Fidda fil-Kategorija tal-Kompetizzjoni ta' Disinn tal-Interfaċċa, Interazzjoni u Esperjenza tal-Utent.

FiddaInterfaċċa· 2025

Viva Cyte Pjattaforma Software Suite

minn Livia Stevenin

Klijent: Cellply

Rebbieħ tal-Premju A' Design Award tal-Fidda fil-Kategorija ta' Interfaċċa

56,621

Rebbieħ ta' Premju Ivverifikat

Ivverifika l-Istatus tal-Premju għal #168358

Żur is-Sit Ara fuq A' Design Award Stqarrija għall-Istampa Badge tal-Premju

Kuluri

Id-Disinn

Dwar Viva Cyte Pjattaforma Software Suite

Viva Cyte hija pjattaforma avvanzata ta' software iddisinjata biex tifforma l-iżvilupp ta' terapija taċ-ċelluli billi tintegra l-awtomazzjoni, analiżi ta' throughput għoli, u esperjenza tal-utent intuwittiva. Hija tikkonsisti minn Software ta' Kontroll (CSW) għall-ġestjoni ta' testijiet bioloġiċi u Software Analitiku (ASW) għall-estrazzjoni ta' għarfien sinifikattiv. L-awtomazzjoni mmexxija mill-AI tnaqqas l-iżball uman, ttejjeb il-preċiżjoni, u ssaħħaħ l-użabbiltà, u tippermetti lir-riċerkaturi jnavigaw flussi tax-xogħol kumplessi b'mod effiċjenti filwaqt li taċċellera l-avvanzi terapewtiċi.

Ir-Rikonoxximent

Dwar il-Premju A' Design Award tal-Fidda

Viva Cyte Pjattaforma Software Suite huwa rebbieħ tal-Premju A' Design Award tal-Fidda, rikonoxximent prestiġjuż straordinarjament mogħti lil disinji tal-ogħla livell, sbieħ u impressjonanti. Ir-rebbieħa tal-Fidda huma xogħlijiet brillanti ħafna u kreattivi ħafna li juru l-għarfien espert, it-talent u l-aċċuratezza tad-disinjaturi tagħhom. Huwa mistenni li Viva Cyte Pjattaforma Software Suite ikun xogħol mill-isbaħ, eżemplari, professjonali ħafna u innovattiv bil-fond. Dan id-disinn rebbieħ tal-Fidda huwa invenzjoni notevoli u mammirata li tikkontribwixxi biex jitwessgħu l-fruntieri tal-arti, ix-xjenza, id-disinn u t-teknoloġija. Viva Cyte Pjattaforma Software Suite huwa ħolqien li ħafna jinvidjawh, li jqajjem ix-xewqat, iġib sentimenti pożittivi u joħloq tgħaġġib u mistagħġib.

Wara d-Disinn

Kit għall-Istampa

Krediti, membri tat-tim u dettalji tekniċi pprovduti mid-disinjatur.

Proprjetajiet Uniċi: The project focused on UX/UI design for two integrated software solutions: Control Software (CSW) for launching and managing biological tests and Analytical Software (ASW) for extracting key insights from results. The design prioritizes scalability, usability, and automation and enables researchers to navigate complex workflows, configure tests, and analyze data with minimal effort, streamlining the entire process.
Dimensjonijiet u Ippakkjar: Design: Figma
Front-end: React JS
Design System: Bento
Tikketti: Cell therapy software, AI-driven automation, biomedical research, UX/UI design, data-driven, workflow optimization, healthcare innovation, regulatory compliance, user-centered design
Teknoloġija tal-Produzzjoni: We conducted extensive user research to design VivaCyte's software suite, including shadowing biologists in labs and interviewing end-users to understand their workflows and challenges. We also organized User Journey Mapping workshops, bringing together biologists and development teams to foster collaboration and gather diverse perspectives. The insights from these activities guided the creation of a custom design system, ensuring consistency and usability across the platforms.
Sfida tad-Disinn: Designing VivaCyte posed challenges in balancing usability, automation, and compliance. Internally, we had to align complex biological workflows with intuitive design, ensuring seamless lab adoption. Externally, strict medical regulations require adherence to compliance standards. Limited industry precedents and evolving AI capabilities pushed us to innovate with user research, iterative prototyping, and AI-driven automation, overcoming barriers in technology and regulatory constraints.
Riċerka: We conducted user research to enhance VivaCyte’s usability and efficiency. Using shadowing and interviews, we observed lab workflows and identified pain points. Data was collected via on-site studies, journey mapping, and prototype testing with biologists and technicians. Insights led to features like printable maps and a guided setup walkthrough, reducing errors and improving efficiency. The research optimized workflows, accelerating cell therapy development.
Ispirazzjoni: Inspired by the need to accelerate cancer cell therapies, VivaCyte was designed to streamline workflows, reduce human error, and enhance patient care. Recognizing the challenges of complex, labour-intensive workflows in cell therapy development, we sought to create a solution that integrates advanced automation, high-throughput analysis, and intuitive design. The design prioritizes usability and scalability, enabling researchers and clinicians to focus on innovation rather than constraints.
Tul tal-Proġett: The project started in January 2022 in Milan and finished in August 2024.
Fluss tal-Operazzjoni: VivaCyte streamlines cell therapy workflows through an intuitive, automated interface. Users launch tests via the Control Software (CSW), which configures experiments that can be followed in real-time, while the Analytical Software (ASW) extracts biological insights and displays them. AI-driven automation minimizes errors, ensuring accuracy and efficiency. Designed for seamless interaction, it simplifies complex tasks, accelerates data analysis, and enhances usability.
Membri tat-Tim: Designer: Sara Bianchini
Designer: Livia Stevenin
Designer: Agnese Ragucci
Krediti tal-Immaġni: Image #1: Mockup: Designed by Freepik, Image: Livia Stevenin (UX/UI designer), Image #2: Livia Stevenin (UX/UI designer), Image #3: Livia Stevenin (UX/UI designer), Image #4: Livia Stevenin (UX/UI designer), Image #5: Livia Stevenin (UX/UI designer),